ArticlePloS one2026
Adverse fetal/neonatal and obstetric outcomes in pregnant women with heart disease: Data from the Registry of Pregnancy and Cardiac Disease (ROPAC) of the Kermanshah, Iran.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPregnancy complicated by heart disease can pose serious risks and complications for both the mother and the fetus. Understanding the prevalence of these conditions during pregnancy, along with the various types of cardiac diseases and their associated complications, is essential for reducing maternal and fetal morbidity and mortality during pregnancy and childbirth.
objectiveThis study aims to examine the clinical characteristics, risk factors, and outcomes of heart disease in pregnant women.
methodsThis single-center prospective registry-based cohort study without a comparison group (single arm) was conducted using data from the Cardiac Disease Registry for pregnant women in Kermanshah, Iran. All pregnant women with structural heart diseases-including congenital heart disease, valvular disease, prosthetic heart valves, cardiomyopathy, ischemic heart disease, aortopathy, and arrhythmias-were included. Data were collected using validated checklists and entered into an online registry.
resultsA total of 36 pregnant women with heart disease were included. The most common diagnoses were congenital heart disease (38.9%), valvular heart disease (30.6%), and cardiomyopathy (22.2%). Most patients (94.5%) had preserved left ventricular ejection fraction (LVEF ≥40%), and 88.9% had pre-existing cardiac disease, with 86.2% receiving pre-pregnancy cardiac counseling. No cases of maternal or neonatal mortality were observed. New-onset heart failure occurred in 13.9% of women, and 27.8% required hospitalization for cardiac reasons during pregnancy. The total abortion rate was 19.4% (11.1% spontaneous, 8.3% therapeutic). Preterm birth occurred in 24.1% of cases, and low birth weight in 17.2%. The cesarean delivery rate was high (80.6%). Hypertensive disorders and gestational diabetes were relatively uncommon. No congenital heart defects were observed in neonates.
conclusionComprehensive pre-pregnancy counseling, specialized prenatal care, and multidisciplinary management can lead to favorable maternal and neonatal outcomes in high-risk pregnancies complicated by heart disease. The absence of mortality in this cohort highlights the effectiveness of organized care models. Despite the limited sample size, these findings underscore the value of structured, registry-based approaches to improving outcomes in pregnant women with cardiac disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.